This announcement is a separate document:
天康生物：2022年第三季度可转换公司债券转股情况的公告
Tiankang Biotech: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.